GSK Files Q2 Report Showing £8.4bn Sales and £1.9bn Savings Plan

GSK's 6-K restates second-quarter 2026 turnover of £8.4 billion, up 5%, alongside a three-year Accelerate Growth programme targeting £1.9 billion in annual savings by 2029.

Andre·2 min read ID: GSK-2026-09-08-1353

TickersGSK Earnings

DeskEarnings

PublishedSep 8, 2026 · 13:53 ET

AccessPro story

GSK reported second-quarter turnover of £8.4 billion across specialty medicines, vaccines and general medicines. — Source: Wikimedia

MORE FROM THE DESK

SEALSQ Doubles H1 Revenue to $11.2M as Losses Widen to $27.8M

KROGER Cuts Same-Store Sales Outlook While Keeping EPS Guidance

MONEYHERO Posts $1.2M Quarterly Loss as Cash Rewards Cut Revenue 13%

CHEMOMETEC Lifts Profit to DKK 201.8M and Guides for Faster Growth